Percutaneous revascularization of an extensively diseased saphenous vein bypass graft with a saphenous vein-covered Palmaz stent

Gurbel, Paul A.; Criado, Frank J.; Curnutte, E. Alan; Patten, Peggy; Secada-Lovio, Jorge

doi:10.1002/(sici)1097-0304(199701)40:1<75::aid-ccd13>3.0.co;2-t

Cited by 8 publications

(1 citation statement)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Like other harvested vascular segments, including autologous cephalic vein and antecubital vein, an autologous SVG was used as a cover for the stents to obliterate coronary artery thrombus,81 aneurysms of the coronary artery,9 or SVG,82 for immediate exclusion of the aneurysm as well as thrombus and maintaining patency compared to conventional stents. The experimental studies have shown a beneficial effect with covered stents on biocompatibility, endothelialization and vascular injury 83…”

Section: Interventional Cardiologymentioning

confidence: 99%

A Reappraisal of Saphenous Vein Grafting

Yuan

Hua

2011

Ann Saudi Med

View full text Add to dashboard Cite

Autologous saphenous vein grafting has been broadly used as a bypass conduit, interposition graft, and patch graft in a variety of operations in cardiac, thoracic, neurovascular, general vascular, vascular access, and urology surgeries, since they are superior to prosthetic veins. Modified saphenous vein grafts (SVG), including spiral and cylindrical grafts, and vein cuffs or patches, are employed in vascular revascularization to satisfy the large size of the receipt vessels or to obtain a better patency. A loop SVG helps flap survival in a muscle flap transfer in plastic and reconstructive surgery. For dialysis or transfusion purposes, a straight or loop arteriovenous fistula created in the forearm or the thigh with an SVG has acceptable patency. The saphenous vein has even been used as a stent cover to minimize the potential complications of standard angioplasty technique. However, the use of saphenous vein grafting is now largely diminished in treating cerebrovascular disorders, superior vena cava syndrome, and visceral revascularization due to the introduction of angioplasty and stenting techniques. The SVG remains the preferable biomaterial in coronary artery bypass, coronary osteoplasty, free flap transfer, and surgical treatment of Peyronie disease. Implications associated with saphenous vein grafting in vascular access surgery for the purpose of dialysis and chemotherapy are considerable. Vascular cuffs and patches have been developed as an important and effective means of enhancing the patency rates of the grafts by linking the synthetic material to the receipt vessel. In addition, saphenous veins can be a cell source for tissue engineering. We review the versatile roles that saphenous vein grafting has played as well as its current status in therapy.

show abstract

Section: Interventional Cardiologymentioning

confidence: 99%